Effects	Effect	NNS	B-NP	O		0	7
of	of	IN	B-PP	O		8	10
a	a	DT	B-NP	O		11	12
probiotic	probiotic	JJ	I-NP	O		13	22
fermented	ferment	VBN	I-NP	O		23	32
milk	milk	NN	I-NP	O		33	37
beverage	beverage	NN	I-NP	O		38	46
containing	contain	VBG	B-VP	O		47	57
Lactobacillus casei	Lactobacillus_casei	NNP	B-NP	O		58	77
strain	strain	NN	I-NP	O		78	84
Shirota	Shirota	NN	I-NP	O		85	92
on	on	IN	B-PP	O		93	95
defecation	defecation	NN	B-NP	O		96	106
frequency	frequency	NN	I-NP	O		107	116
,	,	,	O	O		116	117
intestinal	intestinal	JJ	B-NP	B-protein		118	128
microbiota	microbiota	NNS	I-NP	I-protein		129	139
,	,	,	O	O		139	140
and	and	CC	O	O		141	144
the	the	DT	B-NP	O		145	148
intestinal	intestinal	JJ	I-NP	O		149	159
environment	environment	NN	I-NP	O		160	171
of	of	IN	B-PP	O		172	174
healthy	healthy	JJ	B-NP	O		175	182
individuals	individual	NNS	I-NP	O		183	194
with	with	IN	B-PP	O		195	199
soft	soft	JJ	B-NP	O		200	204
stools	stool	NNS	I-NP	O		205	211
.	.	.	O	O		211	212

The	The	DT	B-NP	O		213	216
effects	effect	NNS	I-NP	O		217	224
of	of	IN	B-PP	O		225	227
drinking	drink	VBG	B-VP	O		228	236
a	a	DT	B-NP	O		237	238
fermented	ferment	VBN	I-NP	O		239	248
milk	milk	NN	I-NP	O		249	253
beverage	beverage	NN	I-NP	O		254	262
that	that	WDT	B-NP	O		263	267
contains	contain	VBZ	B-VP	O		268	276
Lactobacillus casei	Lactobacillus_casei	NNP	B-NP	O		277	296
strain	strain	NN	I-NP	O		297	303
Shirota	Shirota	NN	I-NP	O		304	311
(	(	(	O	O		312	313
LcS	LcS	NN	B-NP	O		313	316
)	)	)	O	O		316	317
at	at	IN	B-PP	O		318	320
40	40	CD	B-NP	O		321	323
billion	billion	CD	I-NP	O		324	331
bacterial	bacterial	JJ	I-NP	B-cell_type		332	341
cells	cell	NNS	I-NP	I-cell_type		342	347
/	/	SYM	B-VP	O		347	348
bottle	bottle	NN	B-NP	O		348	354
for	for	IN	B-PP	O		355	358
4	4	CD	B-NP	O		359	360
weeks	week	NNS	I-NP	O		361	366
(	(	(	O	O		367	368
probiotics	probiotic	NNS	B-NP	O		368	378
,	,	,	O	O		378	379
1	1	CD	B-NP	O		380	381
bottle	bottle	NN	I-NP	O		382	388
/	/	SYM	B-NP	O		388	389
day	day	NN	I-NP	O		389	392
)	)	)	O	O		392	393
on	on	IN	B-PP	O		394	396
defecation	defecation	NN	B-NP	O		397	407
frequency	frequency	NN	I-NP	O		408	417
,	,	,	O	O		417	418
intestinal	intestinal	JJ	B-NP	B-protein		419	429
microbiota	microbiota	NN	I-NP	I-protein		430	440
and	and	CC	O	O		441	444
the	the	DT	B-NP	O		445	448
intestinal	intestinal	JJ	I-NP	O		449	459
environment	environment	NN	I-NP	O		460	471
of	of	IN	B-PP	O		472	474
healthy	healthy	JJ	B-NP	O		475	482
individuals	individual	NNS	I-NP	O		483	494
with	with	IN	B-PP	O		495	499
soft	soft	JJ	B-NP	O		500	504
stools	stool	NNS	I-NP	O		505	511
were	be	VBD	B-VP	O		512	516
evaluated	evaluate	VBN	I-VP	O		517	526
.	.	.	O	O		526	527

Thirty	Thirty	CD	B-NP	O		528	534
-	-	HYPH	I-NP	O		534	535
four	four	CD	I-NP	O		535	539
healthy	healthy	JJ	I-NP	O		540	547
adults	adult	NNS	I-NP	O		548	554
who	who	WP	B-NP	O		555	558
had	have	VBD	B-VP	O		559	562
soft	soft	JJ	B-NP	O		563	567
stools	stool	NNS	I-NP	O		568	574
were	be	VBD	B-VP	O		575	579
randomised	randomise	VBN	I-VP	O		580	590
into	into	IN	B-PP	O		591	595
2	2	CD	B-NP	O		596	597
groups	group	NNS	I-NP	O		598	604
,	,	,	O	O		604	605
and	and	CC	O	O		606	609
the	the	DT	B-NP	O		610	613
effects	effect	NNS	I-NP	O		614	621
of	of	IN	B-PP	O		622	624
a	a	DT	B-NP	O		625	626
regular	regular	JJ	I-NP	O		627	634
4-week	4-week	JJ	I-NP	O		635	641
intake	intake	NN	I-NP	O		642	648
of	of	IN	B-PP	O		649	651
probiotics	probiotic	NNS	B-NP	O		652	662
were	be	VBD	B-VP	O		663	667
evaluated	evaluate	VBN	I-VP	O		668	677
by	by	IN	B-PP	O		678	680
a	a	DT	B-NP	O		681	682
placebo	placebo	NN	I-NP	O		683	690
-	-	HYPH	O	O		690	691
controlled	control	VBN	B-VP	O		691	701
,	,	,	O	O		701	702
double	double	JJ	B-NP	O		703	709
-	-	HYPH	I-NP	O		709	710
blind	blind	JJ	I-NP	O		710	715
,	,	,	I-NP	O		715	716
parallel	parallel	JJ	I-NP	O		717	725
-	-	HYPH	I-NP	O		725	726
group	group	NN	I-NP	O		726	731
comparative	comparative	JJ	I-NP	O		732	743
design	design	NN	I-NP	O		744	750
.	.	.	O	O		750	751

Defecation	Defecation	NN	B-NP	O		752	762
frequency	frequency	NN	I-NP	O		763	772
significantly	significantly	RB	B-ADVP	O		773	786
decreased	decrease	VBD	B-VP	O		787	796
after	after	IN	B-PP	O		797	802
the	the	DT	B-NP	O		803	806
4-week	4-week	JJ	I-NP	O		807	813
intake	intake	NN	I-NP	O		814	820
period	period	NN	I-NP	O		821	827
compared	compare	VBN	B-PP	O		828	836
with	with	IN	B-PP	O		837	841
before	before	RB	O	O		842	848
the	the	DT	B-NP	O		849	852
probiotic	probiotic	JJ	I-NP	O		853	862
treatment	treatment	NN	I-NP	O		863	872
.	.	.	O	O		872	873

The	The	DT	B-NP	O		874	877
stool	stool	NN	I-NP	O		878	883
quality	quality	NN	I-NP	O		884	891
significantly	significantly	RB	B-VP	O		892	905
improved	improve	VBD	I-VP	O		906	914
(	(	(	O	O		915	916
hardened	harden	VBN	B-VP	O		916	924
)	)	)	O	O		924	925
compared	compare	VBN	B-PP	O		926	934
to	to	TO	B-PP	O		935	937
the	the	DT	B-NP	O		938	941
placebo	placebo	NN	I-NP	O		942	949
.	.	.	O	O		949	950

Also	Also	RB	B-ADVP	O		951	955
,	,	,	O	O		955	956
the	the	DT	B-NP	O		957	960
water	water	NN	I-NP	O		961	966
content	content	NN	I-NP	O		967	974
of	of	IN	B-PP	O		975	977
the	the	DT	B-NP	O		978	981
stools	stool	NNS	I-NP	O		982	988
was	be	VBD	B-VP	O		989	992
lower	low	JJR	B-ADJP	O		993	998
in	in	IN	B-PP	O		999	1001
the	the	DT	B-NP	O		1002	1005
probiotic	probiotic	JJ	I-NP	O		1006	1015
group	group	NN	I-NP	O		1016	1021
than	than	IN	B-PP	O		1022	1026
in	in	IN	B-PP	O		1027	1029
the	the	DT	B-NP	O		1030	1033
placebo	placebo	NN	I-NP	O		1034	1041
group	group	NN	I-NP	O		1042	1047
.	.	.	O	O		1047	1048

Live	Live	JJ	B-NP	O		1049	1053
LcS	LcS	NN	I-NP	O		1054	1057
was	be	VBD	B-VP	O		1058	1061
recovered	recover	VBN	I-VP	O		1062	1071
at	at	IN	B-PP	O		1072	1074
6.9	6.9	CD	B-NP	O		1075	1078
±	±	NN	I-NP	O		1079	1080
1.3	1.3	CD	B-NP	O		1081	1084
and	and	CC	I-NP	O		1085	1088
7.2	7.2	CD	I-NP	O		1089	1092
±	±	HYPH	I-NP	O		1093	1094
0.8	0.8	CD	I-NP	O		1095	1098
log(10)	log(10)	NN	I-NP	O		1099	1106
CFU	CFU	NN	I-NP	O		1107	1110
per	per	IN	B-PP	O		1111	1114
1g	1g	NN	B-NP	O		1115	1117
of	of	IN	B-PP	O		1118	1120
stool	stool	NN	B-NP	O		1121	1126
after	after	IN	B-PP	O		1127	1132
2	2	CD	B-NP	O		1133	1134
and	and	CC	I-NP	O		1135	1138
4	4	CD	I-NP	O		1139	1140
weeks	week	NNS	I-NP	O		1141	1146
,	,	,	O	O		1146	1147
respectively	respectively	RB	B-ADVP	O		1148	1160
,	,	,	O	O		1160	1161
of	of	IN	B-PP	O		1162	1164
probiotic	probiotic	JJ	B-NP	O		1165	1174
treatment	treatment	NN	I-NP	O		1175	1184
.	.	.	O	O		1184	1185

The	The	DT	B-NP	O		1186	1189
number	number	NN	I-NP	O		1190	1196
of	of	IN	B-PP	O		1197	1199
bifidobacteria	bifidobacteria	NNS	B-NP	O		1200	1214
in	in	IN	B-PP	O		1215	1217
the	the	DT	B-NP	O		1218	1221
stools	stool	NNS	I-NP	O		1222	1228
also	also	RB	B-ADVP	O		1229	1233
increased	increase	VBD	B-VP	O		1234	1243
significantly	significantly	RB	B-ADVP	O		1244	1257
compared	compare	VBN	B-PP	O		1258	1266
with	with	IN	B-PP	O		1267	1271
the	the	DT	B-NP	O		1272	1275
level	level	NN	I-NP	O		1276	1281
before	before	IN	B-PP	O		1282	1288
starting	start	VBG	B-VP	O		1289	1297
the	the	DT	B-NP	O		1298	1301
probiotics	probiotic	NNS	I-NP	O		1302	1312
.	.	.	O	O		1312	1313

The	The	DT	B-NP	O		1314	1317
organic	organic	JJ	I-NP	O		1318	1325
acid	acid	NN	I-NP	O		1326	1330
levels	level	NNS	I-NP	O		1331	1337
(	(	(	O	O		1338	1339
total	total	JJ	B-NP	O		1339	1344
,	,	,	I-NP	O		1344	1345
acetic	acetic	JJ	I-NP	O		1346	1352
acid	acid	NN	I-NP	O		1353	1357
,	,	,	O	O		1357	1358
propionic	propionic	JJ	B-NP	O		1359	1368
acid	acid	NN	I-NP	O		1369	1373
,	,	,	O	O		1373	1374
and	and	CC	O	O		1375	1378
butyric	butyric	JJ	B-NP	O		1379	1386
acid	acid	NN	I-NP	O		1387	1391
)	)	)	O	O		1391	1392
significantly	significantly	RB	B-ADVP	O		1393	1406
increased	increase	VBD	B-VP	O		1407	1416
compared	compare	VBN	B-PP	O		1417	1425
with	with	IN	B-PP	O		1426	1430
the	the	DT	B-NP	O		1431	1434
level	level	NN	I-NP	O		1435	1440
before	before	IN	B-PP	O		1441	1447
intake	intake	NN	B-NP	O		1448	1454
in	in	IN	B-PP	O		1455	1457
both	both	CC	B-NP	O		1458	1462
the	the	DT	I-NP	O		1463	1466
probiotic	probiotic	JJ	I-NP	O		1467	1476
and	and	CC	I-NP	O		1477	1480
placebo	placebo	NN	I-NP	O		1481	1488
groups	group	NNS	I-NP	O		1489	1495
,	,	,	O	O		1495	1496
but	but	CC	O	O		1497	1500
they	they	PRP	B-NP	O		1501	1505
returned	return	VBD	B-VP	O		1506	1514
to	to	TO	B-PP	O		1515	1517
the	the	DT	B-NP	O		1518	1521
original	original	JJ	I-NP	O		1522	1530
levels	level	NNS	I-NP	O		1531	1537
after	after	IN	B-PP	O		1538	1543
the	the	DT	B-NP	O		1544	1547
end	end	NN	I-NP	O		1548	1551
of	of	IN	B-PP	O		1552	1554
the	the	DT	B-NP	O		1555	1558
intake	intake	JJ	I-NP	O		1559	1565
period	period	NN	I-NP	O		1566	1572
.	.	.	O	O		1572	1573

These	These	DT	B-NP	O		1574	1579
results	result	NNS	I-NP	O		1580	1587
suggest	suggest	VBP	B-VP	O		1588	1595
that	that	IN	B-SBAR	O		1596	1600
probiotic	probiotic	JJ	B-NP	O		1601	1610
fermented	ferment	VBN	I-NP	O		1611	1620
milk	milk	NN	I-NP	O		1621	1625
beverage	beverage	NN	I-NP	O		1626	1634
has	have	VBZ	B-VP	O		1635	1638
an	an	DT	B-NP	O		1639	1641
intestine	intestine	NN	I-NP	O		1642	1651
-	-	HYPH	O	O		1651	1652
conditioning	condition	VBG	B-VP	O		1652	1664
effect	effect	NN	B-NP	O		1665	1671
by	by	IN	B-PP	O		1672	1674
improving	improve	VBG	B-VP	O		1675	1684
the	the	DT	B-NP	O		1685	1688
frequency	frequency	NN	I-NP	O		1689	1698
of	of	IN	B-PP	O		1699	1701
defecation	defecation	NN	B-NP	O		1702	1712
and	and	CC	I-NP	O		1713	1716
stool	stool	NN	I-NP	O		1717	1722
quality	quality	NN	I-NP	O		1723	1730
and	and	CC	O	O		1731	1734
increasing	increase	VBG	B-VP	O		1735	1745
the	the	DT	B-NP	O		1746	1749
intrinsic	intrinsic	JJ	I-NP	O		1750	1759
bifidobacteria	bifidobacteria	NNS	I-NP	O		1760	1774
in	in	IN	B-PP	O		1775	1777
healthy	healthy	JJ	B-NP	O		1778	1785
individuals	individual	NNS	I-NP	O		1786	1797
with	with	IN	B-PP	O		1798	1802
soft	soft	JJ	B-NP	O		1803	1807
stool	stool	NN	I-NP	O		1808	1813
.	.	.	O	O		1813	1814

